Progressive Multifocal Leukoencephalopathy in a Multiple Sclerosis Patient Diagnosed after Switching from Natalizumab to Fingolimod

Background. Natalizumab- (NTZ-) associated progressive multifocal leukoencephalopathy (PML) is a severe and often disabling infectious central nervous system disease that can become evident in multiple sclerosis (MS) patients after NTZ discontinuation. Recently, novel diagnostic biomarkers for the a...

Полное описание

Сохранить в:
Библиографические подробности
Опубликовано в: :Case Rep Neurol Med
Главные авторы: Sinnecker, Tim, Othman, Jalal, Kühl, Marc, Metz, Imke, Niendorf, Thoralf, Kunkel, Annett, Paul, Friedemann, Wuerfel, Jens, Faiss, Juergen
Формат: Artigo
Язык:Inglês
Опубликовано: Hindawi Publishing Corporation 2016
Предметы:
Case Report
Online-ссылка:https://ncbi.nlm.nih.gov/pmc/articles/PMC5138460/
https://ncbi.nlm.nih.gov/pubmed/27994897
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2016/5876798
Метки: Добавить метку
Нет меток, Требуется 1-ая метка записи!

Схожие документы